Human Infection Challenge with Serotype 3 Pneumococcus-Reference-Cited by-同舟云学术

Human Infection Challenge with Serotype 3 Pneumococcus

Published:2022-12-01 Issue:11 Volume:206 Page:1379-1392
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Robinson Ryan E.¹²^ORCID,Mitsi Elena¹^ORCID,Nikolaou Elissavet¹^ORCID,Pojar Sherin¹^ORCID,Chen Tao¹^ORCID,Reiné Jesús¹^ORCID,Nyazika Tinashe K.¹^ORCID,Court James¹,Davies Kelly¹,Farrar Madlen¹^ORCID,Gonzalez-Dias Patricia¹^ORCID,Hamilton Josh¹,Hill Helen¹^ORCID,Hitchins Lisa¹,Howard Ashleigh¹^ORCID,Hyder-Wright Angela¹²^ORCID,Lesosky Maia¹^ORCID,Liatsikos Konstantinos¹^ORCID,Matope Agnes¹^ORCID,McLenaghan Daniella¹^ORCID,Myerscough Christopher¹,Murphy Annabel¹,Solórzano Carla¹^ORCID,Wang Duolao¹^ORCID,Burhan Hassan¹²^ORCID,Gautam Manish²,Begier Elizabeth³,Theilacker Christian³^ORCID,Beavon Rohini³,Anderson Annaliesa S.⁴^ORCID,Gessner Bradford D.³^ORCID,Gordon Stephen B.¹⁵^ORCID,Collins Andrea M.¹²^ORCID,Ferreira Daniela M.¹^ORCID

Affiliation:

1. Clinical Sciences Department, Liverpool School of Tropical Medicine, Liverpool, UK;

2. Respiratory Research Group, Liverpool University Hospitals Foundation Trust, Liverpool, UK;

3. Pfizer Vaccines, Collegeville, Pennsylvania;

4. Vaccines Research and Development, Pfizer Inc, Pearl River, New York; and

5. Malawi Liverpool Wellcome Research Programme, Blantyre, Malawi

Funder

Pfizer

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine